Pathfinder Cell Therapy, Inc. (PFND)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Dec 29, 2025
Pathfinder Cell Therapy Company Description
Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage.
It identifies diabetes, renal disease, myocardial infarction, peripheral vascular disease, and other diseases as potential indications for therapies based on its technology.
The company was founded in 2008 and is headquartered in Cambridge, Massachusetts.
Pathfinder Cell Therapy, Inc.
| Country | United States |
| Founded | 2008 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1 |
| CEO | Richard Franklin |
Contact Details
Address: 12 Bow Street Cambridge, Massachusetts 02138 United States | |
| Phone | 617-245-0289 |
| Website | pathfindercelltherapy.com |
Stock Details
| Ticker Symbol | PFND |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US70319A1060 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Richard L. Franklin M.D., Ph.D. | Founder, Chief Executive Officer, President, Secretary and Executive Director |
| Joerg Gruber | Founder and Chairman |
| John M. Benson | Chief Financial Officer and Treasurer |